Literature DB >> 18199562

Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.

Spyros Pournaras, Alexandros Ikonomidis, Evangelia Neou, Maria Kantzanou, Antonios N Maniatis, Athanassios Tsakris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18199562     DOI： 10.1093/jac/dkm528

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.

Authors:  Ángel Rodríguez-Villodres; José Manuel Ortiz de la Rosa; Rocío Álvarez-Marín; Jerónimo Pachón; Javier Aznar; José Antonio Lepe; Younes Smani
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.

Authors:  Kuei-Hsiang Hung; Ming-Cheng Wang; Ay-Huey Huang; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

3.  A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae.

Authors:  Hansjürg Engel; Moana Mika; Dalia Denapaite; Regine Hakenbeck; Kathrin Mühlemann; Manfred Heller; Lucy J Hathaway; Markus Hilty
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

Review 4.  Relationships between Efflux Pumps and Emergence of Heteroresistance: A Comprehensive Study on the Current Findings.

Authors:  Mohammad Abavisani; Mansoor Kodori; Fariba Akrami; Ali Radfar; Ali Hashemi
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-09-19       Impact factor: 2.585
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.